Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.43 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3330967 | 0.85 | MAOA (0.43) | HSD17B10MAPTSMN1; SMN2HPGDMGLL | |
| SCHEMBL8521589 | 0.84 | MAOA (0.50) | HSD17B10MAPTSMN1; SMN2HPGDMGLL | |
| SCHEMBL7181962 | 0.84 | MAOA (0.50) | HSD17B10SMN1; SMN2TDP1TSHRALOX15 | |
| SCHEMBL26191084 | 0.84 | MAOA (0.48) | HSD17B10MAPTSMN1; SMN2HPGDMGLL | |
| SCHEMBL24986294 | 0.84 | HSD17B10 (0.35) | HSD17B10MAPTSMN1; SMN2HPGDMGLL | |
| SCHEMBL24124200 | 0.84 | MAPT (0.52) | HSD17B10MAPTSMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL19234396 | 0.84 | HPGD (0.52) | HSD17B10MAPTSMN1; SMN2HPGDMGLL | |
| SCHEMBL11289053 | 0.84 | HPGD (0.52) | MAPTSMN1; SMN2HPGDALDH1A1TDP1 | |
| SCHEMBL7181957 | 0.84 | SMN1; SMN2 (0.38) | HSD17B10MAPTSMN1; SMN2HPGDMGLL | |
| Fluoride SCHEMBL5698381 | 0.82 | NOX1 (0.40) | HSD17B10MAPTSMN1; SMN2HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109390631-A | A kind of nickelic tertiary cathode material electrolyte | 东莞东阳光科研发有限公司 | 2019-02-26 | — | — | CN | claimed |
| US-20150073029-A1 | N-ACYL-2-(CYCLO)ALKYPYRROLIDINES AND PIPERIDINES USEFUL AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2015-03-12 | — | — | US | claimed |
| US-20250236723-A1 | RESIN SHEET, LAMINATED BOARD, METAL-CLAD LAMINATED BOARD, PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE | RESONAC CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| CN-113727970-B | Maleimide, curable resin composition, and cured product | DIC株式会社 | 2024-11-15 | — | — | CN | disclosed |
| CN-113767130-B | Curable resin composition | DIC株式会社 | 2024-09-20 | — | — | CN | disclosed |
| US-20240279478-A1 | RESIN COMPOSITION, RESIN FILM, PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE | RESONAC CORPORATION (JP) | 2024-08-22 | — | — | US | disclosed |
| EP-4417652-A1 | RESIN SHEET, LAMINATED BOARD, METAL-CLAD LAMINATED BOARD, PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE | Resonac Corporation (JP) | 2024-08-21 | — | — | EP | disclosed |
| CN-118103456-A | Resin sheet, laminate, metal-clad laminate, printed wiring board, and semiconductor package | 株式会社力森诺科 | 2024-05-28 | — | — | CN | disclosed |
| CN-113748149-B | Curable resin composition | DIC株式会社 | 2024-05-24 | — | — | CN | disclosed |
| EP-4368674-A1 | RESIN COMPOSITION, RESIN FILM, PRINTED WIRING BOARD, AND SEMICONDUCTOR PACKAGE | Resonac Corporation (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-117561309-A | Resin composition, resin film, printed circuit board, and semiconductor package | 株式会社力森诺科 | 2024-02-13 | — | — | CN | disclosed |
| EP-0453885-A2 | Process for the preparation of aromatic amines | BAYER AG (DE) | 1991-10-30 | — | — | EP | disclosed |
| EP-0394542-A1 | Bone marrow cell recovery with synthetic csf inducers | AMERICAN CYANAMID COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0298915-A1 | Pyridylthio-, pyridylsulfinyl- and pyridylsulfonyl-phenyl-thioureas, isothioureas and carbon diimides, their preparation and their use as pesticides | CIBA-GEIGY AG (CH) | 1989-01-11 | — | — | EP | disclosed |
| EP-0169101-B1 | PROCESS FOR PREPARING (HYDROCARBYLTHIO)CYCLIC AMINES | ETHYL CORPORATION (US) | 1988-08-24 | — | — | EP | disclosed |
| US-4594453-A | Reacting hydrocarbyl disulfide with aromatic amine | ETHYL CORPORATION (US) | 1986-06-10 | — | — | US | disclosed |
| EP-0169101-A1 | Process for preparing (hydrocarbylthio)cyclic amines | ETHYL CORPORATION (US) | 1986-01-22 | — | — | EP | disclosed |
| US-4323580-A | Miticidal, fungicidal and ovicidal diphenylsulfenamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-04-06 | — | — | US | disclosed |
| US-4130433-A | N-PHENOXYPHENYL OR N-PHENYLTHIOPHENYL MALEIMIDES | ABBOTT LABORATORIES (US) | 1978-12-19 | — | — | US | disclosed |
| US-3965077-A | VULCANIZATION RETARDERS | THE B. F. GOODRICH COMPANY (US) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150073029-A1 | N-ACYL-2-(CYCLO)ALKYPYRROLIDINES AND PIPERIDINES USEFUL AS FUNGICIDES | NANP, ATL3, CBR3 | HSD17B10 1907/4885MAPT 2707/4885SMN1; SMN2 3794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.